Startseite Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Is N,N-dimethylglycine N-oxide a choline and betaine metabolite?

  • Michael Lever EMAIL logo , Christopher J. McEntyre , Peter M. George und Stephen T. Chambers
Veröffentlicht/Copyright: 30. November 2016

Abstract

Choline metabolism is by oxidation to betaine, which is demethylated to N,N-dimethylglycine; dimethylglycine is oxidatively demethylated to sarcosine. This pathway is important for osmoregulation and as a source of methyl groups. We asked whether another metabolite was involved. We synthesized the N-oxide of dimethylglycine (DMGO) by oxidizing dimethylglycine with peracetic acid, and measured DMGO in human plasma and urine by HPLC-MS/MS with positive ion detection, using two chromatography procedures, based on ion exchange and HILIC separations. The molecular ion DMGOH+ (m/z=120) yielded four significant fragments (m/z=103, 102, 58 and 42). The suspected DMGO peak in human body fluids showed all these fragments, and co-chromatographed with added standard DMGO in both HPLC systems. Typical plasma concentrations of DMGO are under 1 μmol/l. They may be lower in metabolic syndrome patients. Urine concentrations are higher, and DMGO has a higher fractional clearance than dimethylglycine, betaine and choline. It was present in all of over 80 human urine and plasma samples assayed. Plasma DMGO concentrations correlate with plasma DMG concentrations, with betaine and choline concentrations, with the osmolyte myo-inositol, and strongly with urinary DMGO excretion. We conclude that DMGO is probably a normal human metabolite.

Acknowledgements

The study involving 16 healthy students was funded by the Heart Foundation of New Zealand. The study of metabolic syndrome subjects was funded by DuPont Nutrition & Health. The funding bodies had no influence on this study.

References

Atkinson, W., Elmslie, J., Lever, M., Chambers, S.T., and George, P.M. (2008). Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and post methionine load conditions in healthy male subjects. Am. J. Clin. Nutr. 87, 577–585.10.1093/ajcn/87.3.577Suche in Google Scholar

Day, C.R. and Kempson, S.A. (2016). Betaine chemistry, roles, and potential use in liver disease. Biochim. Biophys. Acta 1860, 1098–1106.10.1016/j.bbagen.2016.02.001Suche in Google Scholar

Ejaz, A., Martinez-Guino, L., Goldfine, A.B., Ribas-Aulinas, F., De Nigris, V., Ribó, S., Gonzalez-Franquesa, A., Garcia-Roves, P.M., Li, E., Dreyfuss, J.M., et al. (2016). Dietary betaine supplementation increases fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. Diabetes 65, 902–912.10.2337/db15-1094Suche in Google Scholar

Hoffmann, L., Brauers, G., Gehrmann, T., Häussinger, D., Mayatepek, E., Schliess, F., and Schwahn, B.C. (2013). Osmotic regulation of hepatic betaine metabolism. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G835–G846.10.1152/ajpgi.00332.2012Suche in Google Scholar

Ikutani, Y. and Matsumura, E. (1968). Studies on the syntheses of N,N-dialkyl neutral amino acids and corresponding N-oxides. Memoirs Osuku Kyoiku Univ. 17, 81–88.Suche in Google Scholar

Konstantinova, S.V., Tell, G.S., Vollset, S.E., Nygård, O., Bleie, Ø., and Ueland, P.M. (2008). Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J. Nutr. 138, 914–920.10.1093/jn/138.5.914Suche in Google Scholar

Lever, M. and Slow, S. (2010). The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin. Biochem. 43, 732–744.10.1016/j.clinbiochem.2010.03.009Suche in Google Scholar

Lever, M., McEntyre, C.J., George, P.M, Slow, S., Chambers, S.T., and Foucher, C. (2014a). Fenofibrate causes elevation of betaine excretion but not excretion of other osmolytes by healthy adults. J. Clin. Lipidol. 8, 433–440.10.1016/j.jacl.2014.04.001Suche in Google Scholar

Lever, M., McEntyre C.J., George, P.M., Slow S., Elmslie, J.L., Lunt, H., Chambers S.T., Parry-Strong, A., and Krebs. J.D. (2014b). Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes. Cardiovasc. Drugs Ther. 28, 459–468.10.1007/s10557-014-6542-9Suche in Google Scholar

Mackay, R.J., McEntyre, C.J., Henderson, C., Lever, M., and George, P.M. (2011). Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin. Biochem. Rev. 31, 3–13.Suche in Google Scholar

Mackenzie, C.G. and Frisell, W.R. (1958). The metabolism of dimethylglycine by liver mitochondria. J. Biol. Chem. 232, 417–427.10.1016/S0021-9258(18)70407-9Suche in Google Scholar

McEntyre, C.J., Lever, M., Chambers, S.T., George, P.M., Slow, S., Elmslie, J.L., Florkowski, C.M., Lunt, H., and Krebs, J.D. (2015). Variation of betaine, N,N-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-N-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann. Clin. Biochem. 52, 352–360.10.1177/0004563214545346Suche in Google Scholar PubMed

Obeid, R., Awwad, H.M., Rabagny, Y., Graeber, S., Herrmann, W., and Geisel, J. (2016). Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am. J. Clin. Nutr. 103, 703–711.10.3945/ajcn.115.121269Suche in Google Scholar PubMed

Svingen, G.F.T., Ueland, P.M., Pedersen, E.K.R., Schartum-Hansen, H., Seifert, R., Ebbing, M., Løland, K.H., Tell, G.S., and Nygård, O. (2013). Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler. Thromb. Vasc. Biol. 33, 2041–2048.10.1161/ATVBAHA.113.301714Suche in Google Scholar PubMed

Svingen, G.F., Schartum-Hansen, H., Ueland, P.M., Pedersen, E.R., Seifert, R., Ebbing, M., Bønaa, K.H., Mellgren, G., Nilsen, D.W., Nordrehaug, J.E., et al. (2015). Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. Eur. J. Prev. Cardiol. 22, 743–752.10.1177/2047487314529351Suche in Google Scholar PubMed

Svingen, G.F.T., Schartum-Hansen, H., Pedersen, E.R., Ueland, P.M., Tell, G.S., Mellgren, G., Njølstad, P.R., Seifert, R., Strand, E., Karlsson, T., et al. (2016). Prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clin. Chem. 62, 755–765.10.1373/clinchem.2015.250761Suche in Google Scholar PubMed

Sweeley, C.C. and Horning, E.C. (1957). Rearrangement and decarboxylation reactions of N,N-dimethylglycine oxide. J. Am. Chem. Soc. 79, 2620–2625.10.1021/ja01567a071Suche in Google Scholar

Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., and Hazen, S.L. (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575–1584.10.1056/NEJMoa1109400Suche in Google Scholar PubMed PubMed Central

Tang, W.H., Wang, Z., Fan, Y., Levison, B., Hazen, J.E., Donahue, L.M., Wu, Y, and Hazen, S.L. (2014). Prognostic value of elevated levels of intestinal microbe-generated metabolite, trimethylamine-N-oxide (TMAO), in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908–1914.10.1016/j.jacc.2014.02.617Suche in Google Scholar PubMed PubMed Central

Tang, W.H., Wang, Z., Shrestha, K., Borowski, A.G., Wu, Y., Troughton, R.W., Klein, A.L., and Hazen, S.L. (2015). Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21, 91–96.10.1016/j.cardfail.2014.11.006Suche in Google Scholar PubMed PubMed Central

Ueland, P.M. (2011). Choline and betaine in health and disease. J. Inherit. Metab. Dis. 34, 3–15.10.1007/s10545-010-9088-4Suche in Google Scholar PubMed

Walford, G.A., Ma, Y., Clish, C., Florez, J.C., Wang, T.J., Gerszten R.E., for the Diabetes Prevention Program Research Group. (2016). Metabolite profiles of diabetes incidence and intervention response in the diabetes prevention program. Diabetes 65, 1424–1433.10.2337/db15-1063Suche in Google Scholar PubMed PubMed Central

Wang, Z., Levison, B.S., Hazen, J.E., Donahue, L., Li, X.-M., and Hazen S.L. (2014a). Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal. Biochem. 455, 35–40.10.1016/j.ab.2014.03.016Suche in Google Scholar

Wang, Z., Tang, W.H., Buffa, J.A., Fu, X., Britt, E.B., Koeth, R.A., Levison, B.S., Fan, Y., Wu, Y., Hazen, S.L. (2014b). Prognostic value of choline and betaine depends on intestinal microbiota generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904–910.10.1093/eurheartj/ehu002Suche in Google Scholar

Zeisel, S.H. (2000). Choline: an essential nutrient for humans. Nutrition 16, 669–671.10.1016/S0899-9007(00)00349-XSuche in Google Scholar

Received: 2016-7-31
Accepted: 2016-11-24
Published Online: 2016-11-30
Published in Print: 2017-6-27

©2017 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 27.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hsz-2016-0261/html
Button zum nach oben scrollen